Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Moderate”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00895895
What this trial is testing

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Who this might be right for
Alzheimer Disease
Pfizer 526
Post-approval studies (Phase 4)Study completedNCT01921972
What this trial is testing

The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Charite University, Berlin, Germany 232
Not applicableStudy completedNCT00211159
What this trial is testing

OmegAD (Omega-3 and Alzheimer's Disease)

Who this might be right for
Alzheimer's Disease
Karolinska University Hospital 204
Post-approval studies (Phase 4)Study completedNCT00551161
What this trial is testing

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Northwell Health 12
Not applicableLooking for participantsNCT05926011
What this trial is testing

Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
REGEnLIFE SAS 108
Testing effectiveness (Phase 2)Study completedNCT03230071
What this trial is testing

Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia

Who this might be right for
Vascular Dementia
Dongzhimen Hospital, Beijing 160
Large-scale testing (Phase 3)Ended earlyNCT00550420
What this trial is testing

Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 331
Testing effectiveness (Phase 2)Study completedNCT00940589
What this trial is testing

Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor

Who this might be right for
Alzheimer's DiseaseSleep Disorder
Neurim Pharmaceuticals Ltd. 73
Large-scale testing (Phase 3)Looking for participantsNCT06702124
What this trial is testing

Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
I.R.C.C.S. Fondazione Santa Lucia 348
Not applicableStudy completedNCT02978768
What this trial is testing

Tai Chi 6-Form Sports Apparatus With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Chang Gung Memorial Hospital 67
Post-approval studies (Phase 4)Study completedNCT07417670
What this trial is testing

Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Carnot Laboratories 105
Not applicableStudy completedNCT02711683
What this trial is testing

DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil

Who this might be right for
Alzheimer's Disease
First Affiliated Hospital Xi'an Jiaotong University 92
Not applicableUnknownNCT01709188
What this trial is testing

Musical Dual Task Training to Improve Attention Control for Dementia

Who this might be right for
Dementia
Chang Gung Memorial Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00093951
What this trial is testing

SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Saegis Pharmaceuticals 280
Not applicableLooking for participantsNCT07625241
What this trial is testing

CST+MST Intervention on People Living With Mild-to-moderate Dementia

Who this might be right for
Dementia
Istituto Superiore di Sanità 421
Not applicableWithdrawnNCT04255329
What this trial is testing

Non Verbal Communication and Dementia

Who this might be right for
Neurocognitive DisordersAlzheimer Disease
University Hospital, Montpellier
Early research (Phase 1)Study completedNCT02859207
What this trial is testing

Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

Who this might be right for
Early Alzheimer's Disease
Eisai Inc. 32
Post-approval studies (Phase 4)Study completedNCT00035204
What this trial is testing

The Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 63
Testing effectiveness (Phase 2)Study completedNCT01436045
What this trial is testing

Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.

Who this might be right for
Alzheimer's Disease
HealthPartners Institute 12
Post-approval studies (Phase 4)Looking for participantsNCT05908695
What this trial is testing

An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 1,312
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation